Anti‐hypersensitive effect of angiotensin (1‐7) on streptozotocin‐induced diabetic neuropathic pain in mice

Abstract

Background We have recently reported that the spinal angiotensin (Ang) converting enzyme (ACE)/Ang II/AT1 receptor axis and downstream p38 MAPK phosphorylation are activated in streptozotocin (STZ)‐induced diabetic mice and lead to tactile hypersensitivity. Moreover, our previous results suggested that the intrathecal (i.t.) administration of Ang (1‐7), an N‐terminal fragment of Ang II, may attenuate the Ang II‐induced nociceptive behaviour through the inhibition of p38 MAPK phosphorylation via Mas receptors. Here, we investigated whether the i.t. administration of Ang (1‐7) can attenuate STZ‐induced diabetic neuropathic pain. Methods Tactile and thermal hypersensitivities were determined using the von Frey filament and Hargreaves tests, respectively. The protein expression of ACE2, Mas receptors and phospho‐p38 MAPK was measured by western blotting. Spinal ACE2 activity was determined using ACE2 activity assay kit. Results The i.t. administration of Ang (1‐7) significantly reduced the tactile and thermal hypersensitivities on day 14 after STZ injection, and these effects were significantly prevented by the Mas receptor antagonist A779. The expression of ACE2 and Mas receptors in the plasma membrane fraction of the lumbar dorsal spinal cord was both significantly decreased in STZ mice. Spinal ACE2 activity was also decreased while p38 MAPK phosphorylation was increased in the lumbar dorsal region of these mice. This phosphorylation was attenuated by the injection of Ang (1‐7), whose effect was reversed by A779. Conclusions Our data demonstrate that Ang (1‐7) attenuates STZ‐induced diabetic neuropathic pain and that this occurs through a mechanism involving spinal Mas receptors and he inhibition of p38 MAPK phosphorylation. Significance The ACE2/Ang (1‐7)/Mas receptor axis was down‐regulated in the spinal cord of STZ mice and the i.t. administration of Ang (1‐7) attenuated the STZ‐induced diabetic neuropathic pain via Mas receptors. Therefore, the activation of this axis could be an effective therapeutic target to alleviate the neuropathic pain in diabetic patients.

Acute myelitis after SARS-CoV-2 infection: a case report

“…Moreover, a recent study showed that SARS-CoV-2 can enter the human body via ACE2 receptors on the surface of human cells and cause disease [5] . It is intriguing that ACE2 receptors are also expressed on the membrane of spinal cord neurons [9,10] , further suggesting that SARS-CoV-2 is implicated in acute myelitis based on the specific ACE2 receptors on the surface of spinal cord neurons.…”

“…ACE2 receptors are also expressed on the surface of spinal cord cells [9,10] . Whether spinal cord neurons are implicated in COVID-19 remains unknown.…”

COVID-19-Associated Myelitis, Para/Post Infectious or Infectious Myelitis: A Case Report From the North of Iran

“…This theory is the result of prior research on SARS-CoV [10]. ACE2 receptors are also expressed on the surface of spinal cord cells [11,12]. Accordingly, it is comprehensible that COVID-19 also involves the spinal cord.…”

Neuroinvasive Potential of A Primary Respiratory Pathogen SARS-CoV2: Exploring the Underrecognized

“…The presence of ACE2 receptors on the surface of spinal cord neurons supports the cause of acute myelitis as a post inflectional neurological complication [35,36]. Studies in children with COVID-19 have shown that GM-CSF levels were significantly higher in the cerebrospinal fluid (CSF) in SARS-CoV2 patients with CNS impairments than in the serum sample of SARS-CoV2 patients with classical respiratory illness [39].Cases of SARS-CoV causing encephalitis in patients and the large homologue sequences it shares with SARS-CoV2 makes it likely that new strain can also pose a threat to the CNS.…”